home / stock / egrx / egrx articles

EGRX Articles, Eagle Pharmaceuticals Inc. - From 12/31/23

Stock Information
Company Name: Eagle Pharmaceuticals Inc.
Stock Symbol: EGRX
Market: NASDAQ
Website: eagleus.com
Menu
EGRX EGRX Quote EGRX Short EGRX News EGRX Articles EGRX Message Board
Get EGRX Alerts

News, Short Squeeze, Breakout and More Instantly...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Microvast, Eagle Pharmaceuticals, and Golden Heaven and Encourages Investors to Contact the Firm | Benzinga

NEW YORK, Dec. 30, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds invest...
Eagle Pharmaceuticals Shareholders Still Have Time to Participate in the EGRX Class Action; Contact Robbins LLP Today | Benzinga

SAN DIEGO, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and...

DEADLINE ALERT for GM, EGRX, MRCY, and ON: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders | Benzinga

LOS ANGELES, Dec. 27, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on ...

EAGLE PHARMACEUTICALS SHAREHOLDER ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options | Benzinga

If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and wou...
Eagle Pharmaceuticals (EGRX) Accounting Woes Continue Following Investor Fraud Suit - Hagens Berman | Benzinga

SAN FRANCISCO, Dec. 25, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) investors who suffered substantia...

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investors and Encourages Investors to Contact the Firm Before February 9, 2024 | Benzinga

NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S....

Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman | Benzinga

SAN FRANCISCO, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) investors who suffered substantia...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Eagle Pharmaceuticals, Inc. - EGRX | Benzinga

NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Eagle Pharmaceuticals, Inc. ("Eagle"...

EGRX Alert: Kaplan Fox & Kilsheimer LLP Notifies Eagle Pharmaceuticals Investors of a Class Action and Highlights Upcoming Deadline | Benzinga

NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of inves...

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc. (EGRX) Investors of a Class Action Lawsuit and Upcoming Deadline | Benzinga

NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceutic...
Previous 10 Next 10